Status:
COMPLETED
Incretin Effect in Lean and Obese Subjects
Lead Sponsor:
University Hospital, Gentofte, Copenhagen
Conditions:
Incretin Effect
Insulin Resistance
Eligibility:
MALE
18-70 years
Brief Summary
The incretin effect is markedly reduced in patients with type 2 diabetes. Data support the notion that this deficiency is a consequence of the diabetic state. However, the impact of insulin resistance...
Eligibility Criteria
Inclusion
- Diagnosed with type 2 diabetes for at least 3 months
- Normal blood hemoglobin
- Informed consent
Exclusion
- Liver disease
- Diabetic nephropathy
- Treatment with medication that can not be stopped for 12 hours
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00803296
Start Date
January 1 2006
End Date
June 1 2008
Last Update
January 13 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gentofte Hospital, University of Copenhagen
Hellerup, Copenhagen, Denmark, 2900